HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyoung Doo Shin Selected Research

Bronchial Spasm

1/2017Genetic variants of the gasdermin B gene associated with the development of aspirin-exacerbated respiratory diseases.
11/2012CD55 polymorphisms and risk of aspirin‑exacerbated respiratory disease.
5/2012Association study between TRIM26 polymorphisms and risk of aspirin-exacerbated respiratory disease.
4/2012Potential association of DCBLD2 polymorphisms with fall rates of FEV(1) by aspirin provocation in Korean asthmatics.
10/2011Association of the variants in AGT gene with modified drug response in Korean aspirin-intolerant asthma patients.
8/2011Lack of association between CD58 genetic variations and aspirin-exacerbated respiratory disease in a Korean population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hyoung Doo Shin Research Topics

Disease

66Asthma (Bronchial Asthma)
01/2019 - 06/2003
14Infections
11/2014 - 04/2003
14Hypersensitivity (Allergy)
05/2013 - 10/2009
13Neoplasms (Cancer)
11/2018 - 06/2003
12Hepatocellular Carcinoma (Hepatoma)
07/2015 - 04/2003
10Type 2 Diabetes Mellitus (MODY)
01/2021 - 08/2003
8Chronic Hepatitis B
12/2020 - 04/2003
8Schizophrenia (Dementia Praecox)
05/2017 - 12/2009
8Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2009 - 01/2004
7Nasal Polyps (Nasal Polyp)
12/2014 - 02/2011
7Obesity
09/2009 - 03/2004
6Bronchial Spasm
01/2017 - 08/2011
6Hepatitis B
11/2014 - 10/2003
6Inflammation (Inflammations)
07/2012 - 01/2005
5Rheumatoid Arthritis
03/2015 - 05/2008
4Lung Neoplasms (Lung Cancer)
08/2019 - 01/2007
4Insulin Resistance
01/2018 - 11/2006
4Alcoholism (Alcohol Abuse)
04/2015 - 02/2006
4Osteoporosis
11/2009 - 08/2005
4Genetic Predisposition to Disease (Genetic Predisposition)
11/2008 - 11/2003
3Squamous Cell Carcinoma of Head and Neck
06/2015 - 09/2004
3Tuberculosis (Tuberculoses)
12/2014 - 04/2005
3Carcinogenesis
11/2014 - 07/2010
3Fibrosis (Cirrhosis)
08/2014 - 01/2012
3Pneumonia (Pneumonitis)
11/2010 - 07/2009
3Diabetic Nephropathies (Diabetic Nephropathy)
02/2010 - 03/2006
2Respiratory Tract Diseases (Respiratory Tract Disease)
01/2017 - 01/2014
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2016 - 09/2014
2Pulmonary Tuberculosis
07/2015 - 12/2014
2Gestational Diabetes (Gestational Diabetes Mellitus)
10/2013 - 06/2011
2Idiopathic Pulmonary Fibrosis
08/2013 - 06/2011
2Liver Cirrhosis (Hepatic Cirrhosis)
10/2012 - 01/2012
2Liver Diseases (Liver Disease)
10/2012 - 07/2011
2Disease Susceptibility (Diathesis)
06/2012 - 11/2008
2Polyps
01/2012 - 01/2012
2Immune System Diseases (Immune Disorders)
02/2011 - 04/2003
2Overweight
08/2007 - 05/2006
2Chronic Kidney Failure (Chronic Renal Failure)
08/2007 - 03/2006
1Hirschsprung Disease (Hirschsprung's Disease)
09/2019
1Adenocarcinoma
08/2019
1Aspirin-Induced Asthma
01/2019

Drug/Important Bio-Agent (IBA)

45Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2019 - 07/2005
18Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2004
12DNA (Deoxyribonucleic Acid)IBA
01/2017 - 01/2004
9Immunoglobulin E (IgE)IBA
03/2013 - 06/2003
7Genetic Markers (Genetic Marker)IBA
01/2019 - 01/2007
7EnzymesIBA
06/2015 - 01/2005
7CytokinesIBA
03/2013 - 01/2004
6Interleukin-10 (Interleukin 10)IBA
07/2010 - 04/2003
5MicroRNAs (MicroRNA)IBA
11/2014 - 01/2012
5Messenger RNA (mRNA)IBA
02/2011 - 02/2005
4Interleukin-4 (Interleukin 4)IBA
03/2013 - 01/2004
4Interleukin-8 (Interleukin 8)IBA
04/2012 - 01/2004
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2008 - 10/2003
33' Untranslated Regions (3' UTR)IBA
05/2017 - 04/2012
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
11/2016 - 03/2011
3Peptides (Polypeptides)IBA
03/2015 - 06/2010
3G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
12/2014 - 11/2004
3Dopamine (Intropin)FDA LinkGeneric
10/2014 - 02/2006
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
05/2012 - 06/2010
3Pharmaceutical PreparationsIBA
04/2012 - 07/2011
3Biological ProductsIBA
08/2011 - 07/2005
3Glucose (Dextrose)FDA LinkGeneric
06/2011 - 11/2006
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2010 - 12/2006
3Immunologic Factors (Immunomodulators)IBA
04/2010 - 11/2007
3AutoantibodiesIBA
06/2008 - 01/2004
3ChemokinesIBA
11/2007 - 01/2005
3Interleukin-6 (Interleukin 6)IBA
04/2003 - 01/2003
2Biomarkers (Surrogate Marker)IBA
08/2019 - 06/2015
2CholesterolIBA
01/2018 - 09/2009
2HDL CholesterolIBA
01/2018 - 11/2006
2RNA (Ribonucleic Acid)IBA
05/2017 - 05/2013
2NucleosidesIBA
09/2016 - 09/2014
2Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA
06/2015 - 02/2006
2Serotonin (5 Hydroxytryptamine)IBA
09/2014 - 02/2006
2Metalloproteases (Metalloproteinases)IBA
08/2014 - 06/2010
2DisintegrinsIBA
08/2014 - 06/2010
2Hepatitis B e AntigensIBA
03/2014 - 01/2013
2InterleukinsIBA
01/2013 - 11/2007
2DiscoidinsIBA
04/2012 - 04/2012
2AngiotensinogenIBA
10/2011 - 12/2006
2Protein Isoforms (Isoforms)IBA
03/2011 - 05/2009
2Transcription Factors (Transcription Factor)IBA
12/2010 - 10/2006
2LeukotrienesIBA
10/2010 - 09/2010
2Neurotransmitter Agents (Neurotransmitter)IBA
07/2010 - 06/2010
2Interleukin-18 (Interleukin 18)IBA
04/2010 - 12/2009
2Interleukin-23 (Interleukin 23)IBA
11/2009 - 05/2009
2Interleukin-2 (IL2)IBA
07/2009 - 01/2004
2LigandsIBA
07/2009 - 12/2006
2Prostaglandin H2 Thromboxane A2 ReceptorsIBA
04/2009 - 08/2003
2Interferon Regulatory FactorsIBA
11/2008 - 11/2008
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
08/2007 - 12/2006
2Chemokine CCL5IBA
08/2007 - 12/2006
1LipidsIBA
01/2021
1Apolipoproteins E (ApoE)IBA
01/2021
1Complement Factor B (Factor B)IBA
12/2020
1NADP (NADPH)IBA
09/2019
1ErbB Receptors (EGF Receptor)IBA
08/2019
1SmokeIBA
01/2019

Therapy/Procedure

2Therapeutics
11/2018 - 01/2014